NCT01908738

Brief Summary

The purpose of this study to determine effectiveness of paracervical block, lidocaine spray and only oral analgesic drugs for pain relief during endometrial biopsy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 18, 2013

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 26, 2013

Completed
1 month until next milestone

Study Start

First participant enrolled

September 1, 2013

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2014

Completed
Last Updated

February 23, 2017

Status Verified

March 1, 2014

Enrollment Period

6 months

First QC Date

July 18, 2013

Last Update Submit

February 20, 2017

Conditions

Keywords

Endometrial biopsyparacervical blockLidocaine spraywomenabnormal uterine bleeding

Outcome Measures

Primary Outcomes (1)

  • Effectiveness of paracervical block VS Lidocaine spray during endometrial biopsy ; A randomized controlled trial

    measurement outcome by record Pain score(NRS)\[Numberical rating scale 0-10\] immediately after procedure and 15 minutes after procedure in all groups Group 1(1%Lidocaine) Group 2(10%Lidocaine spray) Group 3 Control group(Placebo) Pain score immediately and Pain score 15 minutes were compared between group by using statistic analysis to indentify the significant of decreasing Pain score for pain relief during endometrial biopsy. And after that the result will used to determine effectiveness of each groups\[ paracervical block, lidocaine spray and only oral analgesic drugs.

    up to 12 months

Secondary Outcomes (1)

  • adverse effects of paracervical block versus lidocaine spray

    up to 12 months

Study Arms (3)

paracervical block with 1%lidocaine and 0.9%NSS spray(placebo)

EXPERIMENTAL

first groups receive paracervical block with 1%lidocaine and 0.9%NSS spray(placebo)

Drug: paracervical block with 1%lidocaine

10%lidocaine spray and paracervical block with 0.9%NSS

EXPERIMENTAL

the second groups receive 10%lidocaine spray and paracervical block with 0.9%NSS(placebo)

Drug: 10%lidocaine spray

receive placebo both paracervical block and spray

PLACEBO COMPARATOR

the third groups receive placebo both paracervical block and spray

Drug: paracervical block with 1%lidocaineDrug: 10%lidocaine spray

Interventions

To determine effectiveness of paracervical block, lidocaine spray and only oral analgesic drugs for pain relief during endometrial biopsy. Pain score(NRS) immediately after procedure and 15 minutes Group 1(1%Lidocaine) Group 2(10%Lidocaine spray) Control group(Placebo) Pain score immediately Pain score 15 minutes

paracervical block with 1%lidocaine and 0.9%NSS spray(placebo)receive placebo both paracervical block and spray
10%lidocaine spray and paracervical block with 0.9%NSSreceive placebo both paracervical block and spray

Eligibility Criteria

Age30 Years - 70 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • abnormal uterine bleeding women
  • indicated for endometrial biopsy

You may not qualify if:

  • contraindications to NSAID or Lidocaine - known sensitivity to these drugs
  • pregnancy
  • genital tract infection
  • coagulation disorder
  • unstable vital signs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Akarawit Jitchanwichai

Songkhla, Hatyai, 90110, Thailand

Location

MeSH Terms

Conditions

Metrorrhagia

Interventions

Anesthesia, Obstetrical

Condition Hierarchy (Ancestors)

Uterine HemorrhageUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AnesthesiaAnesthesia and Analgesia

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
faculty of medicine obstertic and gynecology

Study Record Dates

First Submitted

July 18, 2013

First Posted

July 26, 2013

Study Start

September 1, 2013

Primary Completion

March 1, 2014

Study Completion

August 1, 2014

Last Updated

February 23, 2017

Record last verified: 2014-03

Locations